Correlation Between Viking Therapeutics and Soleno Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Soleno Therapeutics, you can compare the effects of market volatilities on Viking Therapeutics and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Soleno Therapeutics.
Diversification Opportunities for Viking Therapeutics and Soleno Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Soleno is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Soleno Therapeutics go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Soleno Therapeutics
Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Soleno Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Viking Therapeutics is 1.05 times less risky than Soleno Therapeutics. The stock trades about -0.27 of its potential returns per unit of risk. The Soleno Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 4,571 in Soleno Therapeutics on November 2, 2024 and sell it today you would earn a total of 413.00 from holding Soleno Therapeutics or generate 9.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Soleno Therapeutics
Performance |
| Timeline |
| Viking Therapeutics |
| Soleno Therapeutics |
Viking Therapeutics and Soleno Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Soleno Therapeutics
The main advantage of trading using opposite Viking Therapeutics and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Soleno Therapeutics vs. Annexon | Soleno Therapeutics vs. Bolt Biotherapeutics | Soleno Therapeutics vs. Lyra Therapeutics | Soleno Therapeutics vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |